Although these inhibitors of PAI-1 have been extensively studied in models of vascular thrombosis/fibrinolysis, only a few published reports have described the efficacy of anti-PAI-1 therapy in limiting the severity of lung fibrosis. The gene discussed is SERPINE1; the disease is deep vein thrombosis.